Navigating the complexities of mild and moderate covid-19 treatment
- PMID: 40441729
- DOI: 10.1136/bmj.r1016
Navigating the complexities of mild and moderate covid-19 treatment
Conflict of interest statement
Competing interests: The BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare the following other interests: MB has received honorariums from Pfizer, Gilead, and MSD (Merck) for educational talks unrelated to the topic of this article.
Publication types
LinkOut - more resources
Full Text Sources